Squarepoint’s UroGen Pharma URGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-22,831
Closed -$535K 5131
2025
Q4
$535K Buy
+22,831
New +$495K ﹤0.01% 3159
2025
Q3
Sell
-94,309
Closed -$1.29M 5106
2025
Q2
$1.29M Buy
94,309
+61,545
+188% +$591K ﹤0.01% 2451
2025
Q1
$362K Sell
32,764
-17,430
-35% -$186K ﹤0.01% 3587
2024
Q4
$535K Sell
50,194
-57,451
-53% -$688K ﹤0.01% 3671
2024
Q3
$1.37M Buy
+107,645
New +$1.6M ﹤0.01% 2361
2024
Q2
Sell
-63,039
Closed -$946K 4775
2024
Q1
$946K Buy
63,039
+3,349
+6% +$54.7K ﹤0.01% 2640
2023
Q4
$895K Buy
+59,690
New +$775K ﹤0.01% 2602
2023
Q3
Sell
-10,920
Closed -$113K 4319
2023
Q2
$113K Buy
+10,920
New +$120K ﹤0.01% 3344
2021
Q3
Sell
-21,554
Closed -$329K 3463
2021
Q2
$329K Buy
+21,554
New +$390K ﹤0.01% 2460
2019
Q4
Sell
-9,289
Closed -$221K 2834
2019
Q3
$221K Buy
9,289
+3,220
+53% +$105K ﹤0.01% 2040
2019
Q2
$218K Sell
6,069
-7,171
-54% -$264K ﹤0.01% 2076
2019
Q1
$489K Buy
+13,240
New +$555K 0.01% 1495

Other funds holding URGN